Records containing: Peyronie Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-23Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional Platelet Rich Plasma for Peyronie's Disease
-
CLINICAL_TRIALS study record update · 2026-01-16Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
-
CLINICAL_TRIALS study record update · 2026-01-14FIBRONIE: ESTUDIO PILOTO SOBRE EFICACIA Y SEGURIDAD DE FIBRORESTIL® COMO TRATAMIENTO INTRALESIONAL COADYUVANTE EN PACIENTES CON ENFERMEDAD DE PEYRONIE CON TRATAMIENTO ESTÁNDAR
-
CLINICAL_TRIALS study record update · 2026-01-07Impact of Concurrent Low Intensity Shockwave Therapy on Clinical Outcomes With Collagenase Clostridium Histolyticum in Peyronie's Disease: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-08-14A Randomized, Double-Blind, Placebo Controlled, Crossover Trial on Safety and Efficacy of Autologous Platelet-Rich Plasma for Treatment of Peyronie's Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-08Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease.
-
CLINICAL_TRIALS study record update · 2025-02-13Efficacy of a Step-wise Protocol in Optimizing CCH Outcomes in Men With Peyronie's Disease
-
CLINICAL_TRIALS study record update · 2025-01-08Pilot Study to Evaluate the Safety and Efficacy of 3.2% High (HHA) and Low (LHA) Molecular Weight Hyaluronic Acid Sodium Salt [32 Mg (HHA) + 32 Mg (LHA) / 2 Ml] for Intralesional Penile Injection in Peyronie's Disease
-
CLINICAL_TRIALS study record update · 2024-10-01Peyronie Disease Questionnaire (PDQ): Turkish Validation
-
CLINICAL_TRIALS study record update · 2024-09-19Addition of Pelvic CT with Agatston Calcium Score for Patients with Peyronie Disease May Change Management Decisions in Patients with Calcified Plaque
-
CLINICAL_TRIALS study record update · 2024-08-27French Translation and Validation of the PEYronie's Disease QUESTionnaire
-
CLINICAL_TRIALS study record update · 2024-07-31Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease
-
CLINICAL_TRIALS study record update · 2024-05-29Non-ablative Radiofrequency and Low-intensity Shock Wave Therapy in Fibrotic Plaque in Men With Peyronie's Disease: Case Series
-
CLINICAL_TRIALS study record update · 2023-10-10Impact of Focused Low-intensity Shockwave Therapy (LiSWT) in Penile Disorders (Peyronie's Disease, Erectile Dysfunction, or Both), With or Without Intralesional Clostridial Collagenase (Xiaflex) Injection, Compared With Radial Shock Wave Therapy or Xiaflex Therapy
-
CLINICAL_TRIALS study record update · 2022-07-08Novel Nanofat Regenerative Surgical Technique for Peyronies' Disease Treatment With Penile Lenght Conservation and Non-incisional Albuginea Preservation
-
CLINICAL_TRIALS study record update · 2021-09-29Treatment Response to Xiaflex Based on Ultrasound Characterization of Plaque for Men With Peyronie's Disease
-
CLINICAL_TRIALS study record update · 2020-05-01Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum (CCH or Xiapex®): Sexual and Psychological Impact and Results From 156 Patients' Questionnaires Data
-
CLINICAL_TRIALS study record update · 2019-08-09Does Size Matter: A Single Case Experimental Design of Limiting the Depth of Penetration During Intercourse
-
CLINICAL_TRIALS study record update · 2019-03-14A Prospective Randomized Double Blinded Placebo Controlled Clinical Trial Evaluating the Combined Effect of Low-Intensity Extracorporeal Shockwave Therapy (LI-ESWT) and Vacuum Erectile Device Combined With Manipulation Exercises on Peyronies Disease.